Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions.
Fiche publication
Date publication
février 1995
Journal
Anti-cancer drugs
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BARBERI-HEYOB Muriel, Pr CONROY Thierry, Pr MERLIN Jean-Louis
Tous les auteurs :
Barberi-Heyob M, Merlin JL, Vigneron M, Conroy T
Lien Pubmed
Mots clés
Carcinoma, drug therapy, Catheterization, Peripheral, Chemotherapy, Adjuvant, Colorectal Neoplasms, drug therapy, Drug Stability, Fluorouracil, administration & dosage, Heparin, administration & dosage, Humans, Infusions, Intravenous, instrumentation, Liver Neoplasms, drug therapy, Portal Vein, Randomized Controlled Trials as Topic, Thrombosis, prevention & control
Référence
Anticancer Drugs. 1995 Feb;6(1):163-4